![9th S-ECCO IBD Masterclass- Segmental Colectomy in UC: European multicentric study Alice Frontali MD - YouTube 9th S-ECCO IBD Masterclass- Segmental Colectomy in UC: European multicentric study Alice Frontali MD - YouTube](https://i.ytimg.com/vi/aKOLxF6u694/hqdefault.jpg)
9th S-ECCO IBD Masterclass- Segmental Colectomy in UC: European multicentric study Alice Frontali MD - YouTube
![Stream episode Prof. Alessandro Armuzzi. ECCO IBD 2022. Congress highlights by BiogenTalks podcast | Listen online for free on SoundCloud Stream episode Prof. Alessandro Armuzzi. ECCO IBD 2022. Congress highlights by BiogenTalks podcast | Listen online for free on SoundCloud](https://i1.sndcdn.com/artworks-Qxtz7pogaCKyzWR4-yxDHrQ-t500x500.jpg)
Stream episode Prof. Alessandro Armuzzi. ECCO IBD 2022. Congress highlights by BiogenTalks podcast | Listen online for free on SoundCloud
![ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease](https://ioibd.org/wp-content/uploads/2020/04/news-ecco-1080x675.jpg)
ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease
![14th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology 14th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology](https://www.esp-pathology.org/_Resources/Persistent/e63342e3c9fd510184d2343b4232c16550758458/MASTER_ECCO%2719%20Web%20banner_150x100%20%28002%29.jpg)
14th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology
![Peter Bossuyt, ECCO-IBD 2022: Risankizumab in Crohn's Disease - Post Hoc Analysis of ADVANCE, MOTIVATE, and FORTIFY - touchIMMUNOLOGY Peter Bossuyt, ECCO-IBD 2022: Risankizumab in Crohn's Disease - Post Hoc Analysis of ADVANCE, MOTIVATE, and FORTIFY - touchIMMUNOLOGY](https://embed-ssl.wistia.com/deliveries/609958c243bd916768548d33987b8700.webp?image_crop_resized=960x540)
Peter Bossuyt, ECCO-IBD 2022: Risankizumab in Crohn's Disease - Post Hoc Analysis of ADVANCE, MOTIVATE, and FORTIFY - touchIMMUNOLOGY
![COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease](https://ioibd.org/wp-content/uploads/2020/11/front_matter-JCC-Journal-pdf.jpg)